Principal Investigator
Dr. Jaco Jurgens
MBChB (Bloemfontein) 1994 MBL (Unisa) 2002
PI since 2000. Special interests in Diabetes, Mental Health & ADHD, and Infectious Diseases. Over 50 trials conducted at this site.
DJW Navorsing · Est. 2001 · Krugersdorp
Clinical Research.
Community Roots.
DJW Research is a SAHPRA-compliant clinical trials unit linked to Krugersdorp Medical Centre. With over 50 completed trials since 2001, we bring world-class research to the heart of our community practice.
Research at a Glance
50+
Trials Completed
25+
Years Active
4
Sub-Investigators
1
Active Trial
SAHPRA Compliant
24/7 Temperature Monitoring
GCP Certified Team
Community-Based Recruitment
2001
Year Established
50+
Trials Completed
7
Team Members
24/7
Temp Monitoring
Where Community
Meets Clinical Science
DJW Navorsing (Research) was established in 2001 with Dr. Jaco Jurgens as Principal Investigator and one Study Coordinator. Over 25 years, the site has grown into a full multi-disciplinary team conducting SAHPRA-regulated trials across a range of therapeutic areas.
Uniquely positioned within a busy general practice, DJW Research draws on the established patient base of Krugersdorp Medical Centre, as well as neighbouring facilities, pharmacies, and local clinics for participant recruitment.
"A small, but motivated group, who conducts studies with passion and dedication."
The team holds GCP certifications and Dispensing Licences, with dedicated equipment including a SAHPRA-compliant emergency trolley and 24/7 central temperature monitoring.
Key Facts
Established2001 — 25+ years of clinical research
Trials CompletedMore than 50 clinical trials conducted at site
RegulatorySAHPRA compliant — GCP certified team
RecruitmentPractice + neighbouring facilities & clinics
Monitoring24/7 central temperature monitoring on-site
The People Behind
Every Trial
Our dedicated multi-disciplinary team brings decades of combined experience to every study we conduct.
Sub-Investigator & Dispenser
Dr. Hendrik Vermooten
Specialist Physician Private practice since 1999
Conducting clinical trials since 2001. Currently serving as Sub-Investigator and backup Dispenser at DJW Navorsing.
Sub-Investigator & Dispenser
Dr. Merle Potgieter
MBChB (Pretoria) 2018 Diploma Mental Health (CMSA) 2021
GCP certified with a Dispensing Licence. Special interest in Psychiatry. Currently involved in various clinical trials.
Sub-Investigator
Dr. Ann van Staden
BSc & MBBCh (Wits)
Multiple life support and surgical certifications. Supports the trial team as a qualified Sub-Investigator.
Site Manager / Site Study Coordinator
Sr. Zelna Vermooten
B.Soc. Sc. Nursing (UOVS) 1989. Clinical trials since 2001
Responsible for day-to-day running of all trials: source documents, scheduling, sample processing, data entry, and invoicing.
Study Coordinator Admin
Yvonne Gregerowski
Admin / Reception
Supports the DJW Research team with administrative and operational tasks.
Active Clinical Trials
DJW Research is currently enrolling participants for the following studies. Contact us to learn more about eligibility.
Currently Enrolling
Librexia
Atrial Fibrillation
A clinical study investigating treatment options for Atrial Fibrillation (AFib) — an irregular heartbeat condition affecting millions worldwide. Enrollment closed.
Currently Enrolling
Zenith
Hypertension with Cardiovascular Risk
Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Completed Trials
Over 50 trials conducted since 2001. A selection of recently completed studies at DJW Research.
Completed
SHASTA-4
Severe Hypertriglyceridemia
Phase 3 — Plozasiran in adults with severe hypertriglyceridemia. Double-blind, placebo-controlled study.
Protocol: AROAPOC3-3004 · SAHPRA: 20240712
Completed
MUIR-3
Hypertriglyceridemia
Phase 3 — Plozasiran (targeting APOC3) for efficacy and safety in adults with hypertriglyceridemia.
Protocol: AROAPOC3-3009 · SAHPRA: 20240713
Completed
Seqirus
Influenza Vaccine (65+)
Phase 3/3b — MF59-adjuvanted inactivated influenza vaccine vs non-adjuvanted vaccine in adults aged 65 and older.
Protocol: V118_24 · SAHPRA: 20230712
Completed
BI CKD
Chronic Kidney Disease
Phase 2/3 — Oral BI 690517 alone and in combination with empagliflozin over 14 weeks in patients with diabetic and non-diabetic chronic kidney disease.
Protocol: BI1378-0005 · SAHPRA: 20220214
Completed
Evergreen
RSV Vaccine (60+)
Phase 3 — Ad26.RSV.preF-based vaccine for prevention of lower respiratory tract disease caused by RSV in adults aged 60 years and older.
Protocol: VAC18193RSV3001 · SAHPRA: 20210710
Completed
Empathy
COVID-19 Treatment
Phase 3 — Ensovibep (MP0420) in ambulatory adults with symptomatic COVID-19. Randomised, double-blind, placebo-controlled.
Protocol: MP0420-CP302 · SAHPRA: 20200476
Completed
Spectra Clover
COVID-19 Vaccine
Phase 2/3 — CpG 1018/Alum-adjuvanted recombinant SARS-CoV-2 S-protein subunit vaccine (SCB-2019) for prevention of COVID-19 in adults 18+.
Protocol: CLO-SCB-2019-003 · SAHPRA: 20200469
Equipped for
Quality Research
Our site is fully equipped to support the rigorous demands of SAHPRA-regulated clinical trials.
Calibrated Centrifuge
On-site sample processing
Electronic Scale
Precision measurement
−20°C Freezer
Long-term sample storage
2–8°C Refrigeration
IMP & sample cold chain
Blood Pressure Meters
Manual & electronic
Emergency Trolley
SAHPRA compliant
Dedicated Computers
Staff email & data systems
Fibre Internet
High-speed connectivity
Backup Generator & UPS
Uninterrupted power supply
24/7 Temp Monitoring
Central temperature alerts
Get in Touch
For trial enquiries, participant information, or sponsor queries — reach the DJW Research team directly.
Address
70 Shannon Street, Noordheuwel, Krugersdorp, 1739
Research Email
WhatsApp
Practice Telephone
Part of Krugersdorp Medical Centre
DJW Research operates within the Krugersdorp Medical Centre practice. For general medical appointments, chronic care, or other health services, visit the main practice page.
Visit the Practice